Mucosal and invasive fungal infections in HIV/AIDS.

C. A. Hage, M. Goldman, L. J. Wheat

Research output: Contribution to journalReview article

26 Scopus citations


Advances in the management of fungal infections in AIDS justify this review. First, their incidence has fallen with the introduction of potent antiretroviral therapy. Now, most cases occur in patients with advanced HIV disease who have failed multiple antiretroviral regimens, are nonadherent to therapy, or treatment na ve. Immune reconstitution has reduced the incidence of these infections and permitted discontinuation of maintenance therapy. However, the immune response to antiretroviral therapy has resulted in paradoxical worsening in some cases, "so-called immune reconstitution inflammatory syndromes". Finally, new antifungal agents expand our treatment choices. This review updates management of fungal infections in AIDS.

Original languageEnglish (US)
Pages (from-to)236-241
Number of pages6
JournalEuropean journal of medical research
Issue number5
StatePublished - May 31 2002

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Mucosal and invasive fungal infections in HIV/AIDS.'. Together they form a unique fingerprint.

  • Cite this